Neogen Current Ratio 2010-2025 | NEOG
Neogen current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Neogen Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-02-28 | $0.55B | $0.14B | 3.91 |
| 2024-11-30 | $0.57B | $0.15B | 3.77 |
| 2024-08-31 | $0.54B | $0.12B | 4.41 |
| 2024-05-31 | $0.59B | $0.15B | 3.82 |
| 2024-02-29 | $0.60B | $0.16B | 3.82 |
| 2023-11-30 | $0.62B | $0.18B | 3.54 |
| 2023-08-31 | $0.58B | $0.14B | 4.23 |
| 2023-05-31 | $0.59B | $0.15B | 4.03 |
| 2023-02-28 | $0.56B | $0.11B | 5.18 |
| 2022-11-30 | $0.64B | $0.15B | 4.22 |
| 2022-08-31 | $0.61B | $0.07B | 9.07 |
| 2022-05-31 | $0.63B | $0.08B | 8.05 |
| 2022-02-28 | $0.61B | $0.07B | 9.28 |
| 2021-11-30 | $0.61B | $0.06B | 9.75 |
| 2021-08-31 | $0.61B | $0.05B | 12.00 |
| 2021-05-31 | $0.59B | $0.05B | 11.04 |
| 2021-02-28 | $0.56B | $0.05B | 12.09 |
| 2020-11-30 | $0.58B | $0.05B | 12.97 |
| 2020-08-31 | $0.56B | $0.05B | 11.99 |
| 2020-05-31 | $0.54B | $0.05B | 11.08 |
| 2020-02-29 | $0.52B | $0.04B | 13.16 |
| 2019-11-30 | $0.50B | $0.04B | 12.89 |
| 2019-08-31 | $0.47B | $0.04B | 11.71 |
| 2019-05-31 | $0.45B | $0.04B | 11.75 |
| 2019-02-28 | $0.42B | $0.03B | 12.33 |
| 2018-11-30 | $0.41B | $0.04B | 10.69 |
| 2018-08-31 | $0.40B | $0.04B | 10.10 |
| 2018-05-31 | $0.38B | $0.04B | 9.71 |
| 2018-02-28 | $0.35B | $0.04B | 9.44 |
| 2017-11-30 | $0.34B | $0.04B | 8.96 |
| 2017-08-31 | $0.31B | $0.04B | 8.11 |
| 2017-05-31 | $0.29B | $0.04B | 8.14 |
| 2017-02-28 | $0.28B | $0.04B | 7.97 |
| 2016-11-30 | $0.29B | $0.03B | 8.52 |
| 2016-08-31 | $0.27B | $0.03B | 8.23 |
| 2016-05-31 | $0.25B | $0.03B | 8.68 |
| 2016-02-29 | $0.26B | $0.03B | 9.18 |
| 2015-11-30 | $0.25B | $0.03B | 8.02 |
| 2015-08-31 | $0.24B | $0.03B | 8.75 |
| 2015-05-31 | $0.23B | $0.03B | 9.08 |
| 2015-02-28 | $0.22B | $0.03B | 8.19 |
| 2014-11-30 | $0.21B | $0.02B | 8.53 |
| 2014-08-31 | $0.20B | $0.02B | 8.22 |
| 2014-05-31 | $0.19B | $0.03B | 7.56 |
| 2014-02-28 | $0.18B | $0.03B | 7.17 |
| 2013-11-30 | $0.18B | $0.02B | 7.68 |
| 2013-08-31 | $0.18B | $0.02B | 7.79 |
| 2013-05-31 | $0.17B | $0.02B | 9.51 |
| 2013-02-28 | $0.16B | $0.02B | 7.09 |
| 2012-11-30 | $0.15B | $0.02B | 8.33 |
| 2012-08-31 | $0.15B | $0.02B | 8.05 |
| 2012-05-31 | $0.14B | $0.02B | 7.21 |
| 2012-02-29 | $0.14B | $0.02B | 7.81 |
| 2011-11-30 | $0.13B | $0.02B | 7.08 |
| 2011-08-31 | $0.12B | $0.02B | 6.81 |
| 2011-05-31 | $0.12B | $0.02B | 6.88 |
| 2011-02-28 | $0.11B | $0.02B | 5.57 |
| 2010-11-30 | $0.11B | $0.02B | 5.08 |
| 2010-08-31 | $0.10B | $0.02B | 4.90 |
| 2010-05-31 | $0.09B | $0.02B | 5.05 |
| 2010-02-28 | $0.09B | $0.02B | 6.15 |
| 2009-11-30 | $0.09B | $0.02B | 6.08 |
| 2009-08-31 | $0.08B | $0.01B | 6.55 |
| 2009-05-31 | $0.07B | $0.01B | 7.76 |
| 2009-02-28 | $0.07B | $0.01B | 6.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.272B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Medtronic (MDT) | Ireland | $106.425B | 15.09 |
| Haleon (HLN) | United Kingdom | $51.105B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.34 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Prestige Consumer Healthcare (PBH) | United States | $4.233B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.51 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.193B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |